Shenzhen Efung Investment Management Co. Ltd.,(abbreviated as "Efung" or "Efung Capital") is one of Shenzhen's earliest professional venture capital firms and has been rated as"The Top Ten Venture Capital Institutions in Shenzhen" for many years.
Efung Capital has made investments in WeMed, Elicio Therapeutics, TriArm Therapeutics, Zhongyianke Biotech, Tactiva Therapeutics, KBP Biosciences, Centrexion Therapeutics, Ascentage Pharma, Chipscreen Biosciences, Frontier Biotech, Lifotronic, Healthgen Biotech, Aridis Pharmaceuticals, and Resverlogix.